CN109568491A - 一种通便排毒的中药制剂及其制备方法 - Google Patents
一种通便排毒的中药制剂及其制备方法 Download PDFInfo
- Publication number
- CN109568491A CN109568491A CN201910058431.6A CN201910058431A CN109568491A CN 109568491 A CN109568491 A CN 109568491A CN 201910058431 A CN201910058431 A CN 201910058431A CN 109568491 A CN109568491 A CN 109568491A
- Authority
- CN
- China
- Prior art keywords
- parts
- catharsis
- preparation
- toxin expelling
- materia medica
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 68
- 239000003053 toxin Substances 0.000 title claims abstract description 51
- 231100000765 toxin Toxicity 0.000 title claims abstract description 51
- 230000035568 catharsis Effects 0.000 title claims abstract description 44
- 239000002398 materia medica Substances 0.000 title claims abstract description 44
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 25
- 241001116389 Aloe Species 0.000 claims abstract description 24
- 244000037364 Cinnamomum aromaticum Species 0.000 claims abstract description 24
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims abstract description 24
- 240000004307 Citrus medica Species 0.000 claims abstract description 24
- 235000011399 aloe vera Nutrition 0.000 claims abstract description 24
- 210000000582 semen Anatomy 0.000 claims abstract description 24
- 244000223082 Syzygium paniculatum Species 0.000 claims abstract description 23
- 235000016641 Syzygium paniculatum Nutrition 0.000 claims abstract description 23
- 241000234435 Lilium Species 0.000 claims abstract description 22
- 239000002994 raw material Substances 0.000 claims abstract description 21
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 26
- 241000218236 Cannabis Species 0.000 claims description 22
- 235000019441 ethanol Nutrition 0.000 claims description 20
- 239000000706 filtrate Substances 0.000 claims description 20
- 238000010992 reflux Methods 0.000 claims description 14
- 238000001914 filtration Methods 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- 238000000855 fermentation Methods 0.000 claims description 10
- 230000004151 fermentation Effects 0.000 claims description 10
- 238000001035 drying Methods 0.000 claims description 7
- 241000931705 Cicada Species 0.000 claims description 6
- 241000233866 Fungi Species 0.000 claims description 5
- 241000235342 Saccharomycetes Species 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- 238000004064 recycling Methods 0.000 claims description 5
- 229920002472 Starch Polymers 0.000 claims description 4
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 4
- 235000019698 starch Nutrition 0.000 claims description 4
- 239000008107 starch Substances 0.000 claims description 4
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 3
- 239000008187 granular material Substances 0.000 claims description 3
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 3
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 3
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 3
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 2
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 claims description 2
- 229920002125 Sokalan® Polymers 0.000 claims description 2
- 229960002233 benzalkonium bromide Drugs 0.000 claims description 2
- KHSLHYAUZSPBIU-UHFFFAOYSA-M benzododecinium bromide Chemical compound [Br-].CCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 KHSLHYAUZSPBIU-UHFFFAOYSA-M 0.000 claims description 2
- 239000002775 capsule Substances 0.000 claims description 2
- 229960001631 carbomer Drugs 0.000 claims description 2
- 229940110456 cocoa butter Drugs 0.000 claims description 2
- 235000019868 cocoa butter Nutrition 0.000 claims description 2
- 239000002552 dosage form Substances 0.000 claims description 2
- 239000000839 emulsion Substances 0.000 claims description 2
- 229940100688 oral solution Drugs 0.000 claims description 2
- -1 oral solution Substances 0.000 claims description 2
- 239000006072 paste Substances 0.000 claims description 2
- 229960000502 poloxamer Drugs 0.000 claims description 2
- 229920001983 poloxamer Polymers 0.000 claims description 2
- 229940032147 starch Drugs 0.000 claims description 2
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 claims 1
- 235000010234 sodium benzoate Nutrition 0.000 claims 1
- 239000004299 sodium benzoate Substances 0.000 claims 1
- 229960003885 sodium benzoate Drugs 0.000 claims 1
- 206010010774 Constipation Diseases 0.000 abstract description 38
- 230000000694 effects Effects 0.000 abstract description 19
- 239000003814 drug Substances 0.000 abstract description 17
- 230000001737 promoting effect Effects 0.000 abstract description 7
- 230000006378 damage Effects 0.000 abstract description 4
- 230000029087 digestion Effects 0.000 abstract description 4
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 abstract description 3
- 230000036039 immunity Effects 0.000 abstract description 3
- 230000000638 stimulation Effects 0.000 abstract description 3
- 240000004308 marijuana Species 0.000 abstract 1
- 238000011282 treatment Methods 0.000 description 26
- 210000004072 lung Anatomy 0.000 description 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 210000004185 liver Anatomy 0.000 description 9
- 230000013872 defecation Effects 0.000 description 8
- 201000010099 disease Diseases 0.000 description 8
- 229940079593 drug Drugs 0.000 description 8
- 239000000796 flavoring agent Substances 0.000 description 8
- 235000019634 flavors Nutrition 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- 235000009508 confectionery Nutrition 0.000 description 7
- 210000000936 intestine Anatomy 0.000 description 7
- 210000002429 large intestine Anatomy 0.000 description 7
- 206010011224 Cough Diseases 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 230000007812 deficiency Effects 0.000 description 6
- 210000000952 spleen Anatomy 0.000 description 6
- 208000002193 Pain Diseases 0.000 description 5
- 210000001124 body fluid Anatomy 0.000 description 5
- 239000010839 body fluid Substances 0.000 description 5
- 210000003734 kidney Anatomy 0.000 description 5
- 238000011084 recovery Methods 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- 206010006326 Breath odour Diseases 0.000 description 4
- 208000032139 Halitosis Diseases 0.000 description 4
- 206010062717 Increased upper airway secretion Diseases 0.000 description 4
- 208000026435 phlegm Diseases 0.000 description 4
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 3
- 238000009825 accumulation Methods 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000005906 menstruation Effects 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 230000002035 prolonged effect Effects 0.000 description 3
- 230000003442 weekly effect Effects 0.000 description 3
- 206010008570 Chloasma Diseases 0.000 description 2
- 241000721047 Danaus plexippus Species 0.000 description 2
- 206010013789 Dry throat Diseases 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical group [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 208000003351 Melanosis Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 206010036790 Productive cough Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 241000700647 Variola virus Species 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 239000003974 emollient agent Substances 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 238000002309 gasification Methods 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 239000002085 irritant Substances 0.000 description 2
- 231100000021 irritant Toxicity 0.000 description 2
- 238000011031 large-scale manufacturing process Methods 0.000 description 2
- 239000008141 laxative Substances 0.000 description 2
- 230000002475 laxative effect Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- IWHVCHNCTHGORM-UHDJGPCESA-M potassium;(e)-3-phenylprop-2-enoate Chemical compound [K+].[O-]C(=O)\C=C\C1=CC=CC=C1 IWHVCHNCTHGORM-UHDJGPCESA-M 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 206010006100 Bradykinesia Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 244000301850 Cupressus sempervirens Species 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 206010018045 Gastroptosis Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 208000006083 Hypokinesia Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 208000015817 Infant Nutrition disease Diseases 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 206010028372 Muscular weakness Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 206010043866 Tinea capitis Diseases 0.000 description 1
- 206010046814 Uterine prolapse Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000009098 adjuvant therapy Methods 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 210000002255 anal canal Anatomy 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 229960004365 benzoic acid Drugs 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 210000002683 foot Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000002650 habitual effect Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 235000001497 healthy food Nutrition 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 230000004377 improving vision Effects 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 208000028774 intestinal disease Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000011866 long-term treatment Methods 0.000 description 1
- 235000004213 low-fat Nutrition 0.000 description 1
- 230000001050 lubricating effect Effects 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 230000036473 myasthenia Effects 0.000 description 1
- 210000004179 neuropil Anatomy 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 235000010241 potassium sorbate Nutrition 0.000 description 1
- 239000004302 potassium sorbate Substances 0.000 description 1
- 229940069338 potassium sorbate Drugs 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 201000010727 rectal prolapse Diseases 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 208000009146 rhinoscleroma Diseases 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229940083542 sodium Drugs 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 208000009189 tinea favosa Diseases 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/482—Cassia, e.g. golden shower tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8967—Lilium, e.g. tiger lily or Easter lily
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Nutrition Science (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种通便排毒的中药制剂及其制备方法,属于中药制剂技术领域。所述通便排毒的中药制剂,由如下重量份数的原料制成:芦荟150‑400份、决明子60‑200份、郁李仁100‑300份、当归60‑200份、黄精40‑200份、玉竹40‑120份、枳实100‑300份、百合40‑120份、火麻仁50‑150份和黑芝麻60‑200份。本发明还公开了上述通便排毒的中药制剂的制备方法。本发明的通便排毒的中药制剂,一是具有改善脾胃、促进通便排毒的功效,能迅速有效地治疗便秘,排出毒素;二是能促进消化、增强免疫力,减少了对肠道的刺激和其它生理损伤;三是疗效显著,无副作用,停药后不易复发。
Description
技术领域
本发明涉及一种通便排毒的中药制剂及其制备方法,属于中药制剂技术领域。
背景技术
便秘是一种常见的多发病,随着人们生活水平的不断提高、饮食习惯的改变和工作节奏的加快,便秘长期困扰着人们的日常生活,特别是妇女产后、老年人、习惯性便秘等阴虚便秘患者,更是苦不堪言。
便秘不仅是肛肠病发病的诱因,还可加重许多全身性疾病,而且许多疾病也能引起一次性或长期便秘。便秘从根本上说,是指粪便在肛管内通过困难,运出时间延长,排出次数减少,粪便硬结,排出困难的症状。中医认为,便秘主要由燥热内结、气机郁滞、津液不足和脾肾虚寒所引起。
目前临床上治疗便秘的药物主要有:容积性泻药、刺激性泻药、润滑性泻药、渗透性缓泻药等。容积性泻药主要代表药是硫酸镁,但由于它不能使结肠张力增加,不宜用于肠道运动迟缓的病人。刺激性泻药因为刺激肠黏膜和肠壁神经丛,并可能引起大肠肌无力,形成药物依赖,因而主要用于大便嵌顿和需要迅速脏腑者,不宜长期应用。润滑性泻药主要的缺点是口感差,作用弱,长期应用会引起脂溶性维生素吸收不良。渗透性缓泻药的主要缺点是在细菌作用下发酵产生气体,引起腹胀等不适感。
综上,亟需开发一种新的通便排毒的中药制剂及其制备方法,来弥补上述缺陷。
发明内容
本发明的目的之一,是提供一种通便排毒的中药制剂。本发明的通便排毒的中药制剂,一是具有改善脾胃、促进通便排毒的功效,能迅速有效地治疗便秘,排出毒素;二是能促进消化、增强免疫力,又大大的减少了对肠道的刺激和其它生理损伤;三是疗效显著,无副作用,停药后不易复发,适用于患有慢性便秘的人群。
本发明解决上述技术问题的技术方案如下:一种通便排毒的中药制剂,由如下重量份数的原料制成:芦荟150-400份、决明子60-200份、郁李仁100-300份、当归60-200份、黄精40-200份、玉竹40-120份、枳实100-300份、百合40-120份、火麻仁50-150份和黑芝麻60-200份。
中医学在长期的治疗实践中积累了丰富的临床经验。为达到上述目的,本申请的发明人根据祖国医学对便秘等肠道疾病的认识及治疗原则,参考现代药理研究成就和以前的各种验方,去糟取精,按中医理论使用科学的发酵技术,得到了本发明的通便排毒的中药制剂。本发明的配方中各原料都符合中国药典规范的要求,都在中国药典2015版规定用量范围内,且无配伍禁忌。同时又是国家食品药品监督管理局批准可使用的保健食品原料,中药原料用于保健食品药食同源,具有安全性,可长期食用等特点,起到调理机体、辅助治疗的作用。
本发明选取的原料介绍:
芦荟,味苦,性寒,归肝、大肠经,有清肝热、通便之功效,用于治疗便秘、小儿疳积、惊风、外治湿癣等病症。
决明子,味苦,性微寒,归肝、大肠经,有清热明目、润肠通便之功效。
郁李仁,味辛、苦、甘、性平,归脾、小肠经,有润肺滑肠,下气利水之功效,用于治疗大肠气滞、燥涩不通、小便不利、大腹水肿、四肢浮肿、脚气等病症。
当归,味甘、辛,性温,归肝、心、脾经,有活血止痛、补血调经、润肠通便之功效,用于治疗血虚眩晕、月经不调、经闭、痛经、面色萎黄、虚寒腹痛、跌打损伤、风湿痹痛、痈疽疮疡、肠燥便秘等病症。
黄精,味甘,性平,归脾、肺、肾经,有补中益气、润心肺、强筋骨之功效,用于治疗虚损寒热、肺痨咳血、病后体虚食少、筋骨软弱、风湿疼痛、风癞癣疾等病症。
玉竹,味甘,性微寒,归肺、胃经,有养阴、润燥、生津、除烦、止渴之功效,用于治疗肺胃阴伤、燥热咳嗽、虚劳咳嗽、咽干口渴、内热消渴、阴虚外感等病症。
枳实,味辛、酸、苦,性温,归脾、胃经,有破气消积、化痰散痞之功效,用于治疗积滞内停、痞满胀痛、泻痢后重、大便不通、痰滞气阻胸痹、结胸、胃下垂、脱肛、子宫脱垂等病症。
百合,味甘,性平,归心、肺经,有润肺止咳、养阴消热、清心安神之功效。
火麻仁,味甘,性平,有润肠通便之功效,用于治疗大便干结、老人和产妇便秘等病症。
黑芝麻,味甘,性平,归肝、肺、肾经,有滋补肝肾、生津润肠、润肤护发、明目之功效,用于治疗血虚津亏、肠燥便秘等病症。
中药方解:
方中的芦荟能入大肠,泻积热、润肠燥、通大便、除积滞,为君药。方中的枳实、郁李仁破气消积、化痰散痞,又能下气利尿,可通大、小肠之秘结,能增加肠道津液,润滑作用好,有利于宿便脱落排除,用于治疗积滞内停、痞满胀痛、泻痢后重、大便不通,可以有效地排除大肠中的毒素,为臣药。方中的玉竹、决明子、百合用于清肝明目,止咳化痰,平肝潜阳,治疗肺胃阴伤、燥热咳嗽、虚劳咳嗽、咽干口渴、内热消渴、阴虚外感,它在胃肠中有气化作用,通过气化可使“夕室”中的宿便脱出,理气开郁,有利于宿便排除体外,为佐药。人的胃肠内一旦有毒,就容易肝火上炎,肝阳上亢,产生头痛,眩晕,视物模糊,还容易痰湿咳嗽,采用单纯泻下,容易造成养份流失,所以方中采用的黄精、当归、黑芝麻有补中益气、滋补肝肾、生津润肠、活血止痛、补血调经、润心肺、强筋骨,面色萎黄肠燥便秘等病症,为使药。排毒过程中,排除大量的油污、杂物、积便、毒素,肠胃内空了不行,排出糟柏的同时必须要吸纳养分,所以采用即能消食导滞,又能健脾开胃的药物,因此服用本药物期间不会降低食欲。以上原料君、臣、佐、使协同作用,共同达到改善脾胃、通便排毒之功效。
服药方法:取上述通便排毒的中药制剂,加入到米汤中,口服。每天三次,每次3.5g-7g。一个月为一疗程,一般两到三个疗程痊愈。
在上述技术方案的基础上,本发明还可以做如下改进。
进一步,由如下重量份数的原料制成:芦荟360份、决明子120份、郁李仁160份、当归120份、黄精40份、玉竹120份、枳实220份、百合120份、火麻仁50份和黑芝麻120份。
进一步,由如下重量份数的原料制成:芦荟340份、决明子140份、郁李仁220份、当归120份、黄精90份、玉竹70份、枳实180份、百合60份、火麻仁80份和黑芝麻90份。
进一步,由如下重量份数的原料制成:芦荟300份、决明子160份、郁李仁200份、当归60份、黄精180份、玉竹40份、枳实200份、百合40份、火麻仁130份和黑芝麻60份。
本发明的目的之二,是提供上述通便排毒的中药制剂的制备方法。本发明的通便排毒的中药制剂的制备方法简单,成本低廉,市场前景广阔,适合规模化生产。
本发明解决上述技术问题的技术方案如下:一种通便排毒的中药制剂的制备方法,包括如下步骤:
步骤1:取如下重量份数的原料:芦荟150-400份、决明子60-200份、郁李仁100-300份、当归60-200份、黄精40-200份、玉竹40-120份、枳实100-300份、百合40-120份、火麻仁50-150份和黑芝麻60-200份;
步骤2:取郁李仁、火麻仁、决明子和芦荟,混合后,采用40%v/v-80%v/v的乙醇回流1-3次,每次1-3小时,过滤、回收乙醇,浓缩,得到醇回流浸膏;
步骤3:取当归、枳实、百合、黄精、玉竹和黑芝麻,加入5-10倍量的水,煎煮1-3小时,过滤,得一次滤渣和一次滤液,向一次滤渣中再加入5-10倍量的水,煎煮1-3小时,过滤,得二次滤渣和二次滤液;合并一次滤液和二次滤液,减压浓缩,得到浸膏;
步骤4:合并步骤2得到的醇回流浸膏和步骤3得到的浸膏,加入药用菌和酵母菌发酵,低温干燥,加入药用辅料,即得到所述通便排毒的中药制剂。
在上述技术方案的基础上,本发明还可以做如下改进。
进一步,步骤3中,所述浸膏在65℃-70℃相对密度为1.01。
进一步,步骤4中,所述药用菌为金蝉花粉;所述发酵温度为28℃-35℃,发酵时间为18h-30h。
采用上述进一步的有益效果是:金蝉花粉包含二大类与人类密切相关的大型真菌——食用菌和药用菌,其中的食用菌不仅富含蛋白质、氨基酸及多糖等营养物质,而且还含有人体所必需的微量元素,具有高蛋白、低脂肪、低糖、低盐和低热量等特点。我国将发展“营养、保健、益智、抗衰老”的菌类保健营养食品,列为食品加工业的重点发展领域之一。
进一步,步骤4中,所述低温干燥的温度为50℃-65℃,时间为8h-12h
进一步,步骤4中,所述药用辅料为淀粉、微晶纤维素、可可豆脂、卡波姆、苯甲酸钠、泊洛沙姆、苯扎溴铵中的一种或多种。
进一步,步骤4中,所述通便排毒的中药制剂的剂型为粉剂、颗粒剂、口服液、胶囊剂、膏剂、乳剂和咀嚼剂中的一种或多种。
本发明的有益效果:
(1)本发明的通便排毒的中药制剂,一是具有改善脾胃、促进通便排毒的功效,能迅速有效地治疗便秘,排出毒素;二是能促进消化、增强免疫力,又大大的减少了对肠道的刺激和其它生理损伤;三是疗效显著,无副作用,停药后不易复发,适用于患有慢性便秘的人群。
(2)本发明的通便排毒的中药制剂的制备方法简单,原料易得、成本低廉,市场前景广阔,适合规模化生产。
具体实施方式
以下结合具体实施例对本发明的原理和特征进行描述,所举实例只用于解释本发明,并非用于限定本发明的范围。
实施例1
本实施例的通便排毒的中药制剂,由如下重量的原料制成:芦荟260kg、决明子120kg、郁李仁160kg、当归180kg、黄精40kg、玉竹120kg、枳实180kg、百合120kg、火麻仁50kg和黑芝麻150kg。
上述通便排毒的中药制剂的制备方法,包括如下步骤:
步骤1:取如下重量的原料:芦荟260kg、决明子120kg、郁李仁160kg、当归180kg、黄精40kg、玉竹120kg、枳实180kg、百合120kg、火麻仁50kg和黑芝麻150kg;
步骤2:取郁李仁、火麻仁、决明子和芦荟,混合后,采用40%的乙醇回流1次,每次1小时,过滤、回收乙醇,浓缩,得到醇回流浸膏;
步骤3:取当归、枳实、百合、黄精、玉竹和黑芝麻,加入5倍量的水,煎煮1小时,过滤,得一次滤渣和一次滤液,一次滤渣再加入5倍量的水,煎煮1小时,过滤,得二次滤渣和二次滤液;合并一次滤液和二次滤液,减压浓缩,得到浸膏,该浸膏在65℃-70℃相对密度为1.01;
步骤4:合并步骤2得到的醇回流浸膏和步骤3得到的浸膏,加入1kg金蝉花粉和1kg酵母菌,于35℃发酵时间为18h,于50℃低温干燥时间为8h,加入淀粉45kg、低聚果糖60kg和肉桂酸钾1kg,按常规工艺制成丸剂,每丸0.2g,即得到所述通便排毒的中药制剂。
用法与用量:每天2次,每次20-30丸,一个月一个疗程,一到三个疗程痊愈。
实施例2
本实施例的通便排毒的中药制剂,由如下重量的原料制成:芦荟340kg、决明子140kg、郁李仁220kg、当归120kg、黄精90kg、玉竹70kg、枳实180kg、百合60kg、火麻仁80kg和黑芝麻90kg。
上述通便排毒的中药制剂的制备方法,包括如下步骤:
步骤1:取如下重量的原料:芦荟340kg、决明子140kg、郁李仁220kg、当归120kg、黄精90kg、玉竹70kg、枳实180kg、百合60kg、火麻仁80kg和黑芝麻90kg;
步骤2:取郁李仁、火麻仁、决明子和芦荟,混合后,采用60%的乙醇回流2次,每次2小时,过滤、回收乙醇,浓缩,得到醇回流浸膏;
步骤3:取当归、枳实、百合、黄精、玉竹和黑芝麻,加入8倍量的水,煎煮2小时,过滤,得一次滤渣和一次滤液,一次滤渣再加入8倍量的水,煎煮2小时,过滤,得二次滤渣和二次滤液;合并一次滤液和二次滤液,减压浓缩,得到浸膏,该浸膏在65℃-70℃相对密度为1.01;
步骤4:合并步骤2得到的醇回流浸膏和步骤3得到的浸膏,加入1kg金蝉花粉和1kg酵母菌,于30℃发酵时间为24h,于58℃低温干燥时间为10h,加入微晶纤维素36kg、低聚果糖50kg和山梨酸钾1kg,按常规工艺制成颗粒剂,装袋,每袋3.5g,即得到所述通便排毒的中药制剂。
用法与用量:每天2次,每次1-2袋,一个月一个疗程,一到三个疗程痊愈。
实施例3
本实施例的通便排毒的中药制剂,由如下重量的原料制成:芦荟300kg、决明子150kg、郁李仁200kg、当归60kg、黄精180kg、玉竹40kg、枳实120kg、百合40kg、火麻仁150kg和黑芝麻60kg。
上述通便排毒的中药制剂的制备方法,包括如下步骤:
步骤1:取如下重量的原料:芦荟300kg、决明子150kg、郁李仁200kg、当归60kg、黄精180kg、玉竹40kg、枳实120kg、百合40kg、火麻仁150kg和黑芝麻60kg;
步骤2:取郁李仁、火麻仁、决明子和芦荟,混合后,采用80%的乙醇回流3次,每次3小时,过滤、回收乙醇,浓缩,得到醇回流浸膏;
步骤3:取当归、枳实、百合、黄精、玉竹和黑芝麻,加入10倍量的水,煎煮3小时,过滤,得一次滤渣和一次滤液,一次滤渣再加入10倍量的水,煎煮3小时,过滤,得二次滤渣和二次滤液;合并一次滤液和二次滤液,减压浓缩,得到浸膏,该浸膏在65℃-70℃相对密度为1.01;
步骤4:合并步骤2得到的醇回流浸膏和步骤3得到的浸膏,加入1kg金蝉花粉和1kg酵母菌,于32℃发酵时间为30h,于65℃低温干燥时间为12h,加入淀粉40kg、低聚果糖55kg和肉桂酸钾1kg,按常规工艺制成粉剂,装袋,每袋3.5g,即得到所述通便排毒的中药制剂。
用法与用量:每天2次,每次1-2袋,一个月一个疗程,一到三个疗程痊愈。
典型临床例1
历某,女,北京昌平区人,部队军官,36岁。自诉乏力,面色暗黄,便秘3年多,大便每4-7天1次。服用实施例1得到的治疗便秘的中药制剂,每天2次,每次20丸。一个疗程后,大便每二天一次,后又服用2个疗程,排便每天一次,继续服用一个疗程后体重降了5公斤,排便恢复正常,面色红润,身体轻松。
典型临床例2
武某,女,河北保定人,29岁,未婚。自诉便秘5年,大便3-5天一次。有口臭,脸上有黄褐斑。服用实施例2得到的治疗便秘的中药制剂,每天2次,每次1-2袋。一个疗程后,大便1-2天一次,继续服用二个疗程,每天大便每天一次。口臭没了黄褐斑淡了很多,自己非常满意。
典型临床例3
李某,男,北京丰台区人,31岁,经商。自诉便秘6年,脸上身上都有痘痘。每周大便1-2次。服用实施例3得到的治疗便秘的中药制剂,每天2次,每次1-2袋。两个疗程后,大便每天一次,体重降了6公斤,脸上和身上痘痘没有了,皮肤平滑。
典型临床例4
赵某,女,北京市昌平区人,24岁,身高1.63米,皮肤黑、便秘,月经量少有血块。服用实施例1得到的治疗便秘的中药制剂,每天2次,每次20丸。三个疗程后,大便每天一次,皮肤较以前白皙,月经恢复正常,心情愉悦。
典型临床例5
安某,男,北京市东城区人,42岁。自诉便秘多年,每周排便一次,肥胖,血脂高、血压高、血糖高。服用实施例2得到的治疗便秘的中药制剂,每天2次,每次1-2袋。一个疗程后,每天排便一次,继续服用两个疗程。便秘康复未犯,三高接近正常。
典型临床例6
郑某,男,辽宁沈阳人,55岁。自诉便秘10多年,每周排便1-2次,口臭。服用实施例3得到的治疗便秘的中药制剂,每天2次,每次1-2袋。三个疗程后,大便恢复正常,体重降了8公斤,口臭也没有了。
以上所述仅为本发明的较佳实施例,并不用以限制本发明,凡在本发明的精神和原则之内,所作的任何修改、等同替换、改进等,均应包含在本发明的保护范围之内。
Claims (10)
1.一种通便排毒的中药制剂,其特征在于,由如下重量份数的原料制成:芦荟150-400份、决明子60-200份、郁李仁100-300份、当归60-200份、黄精40-200份、玉竹40-120份、枳实100-300份、百合40-120份、火麻仁50-150份和黑芝麻60-200份。
2.根据权利要求1所述的通便排毒的中药制剂,其特征在于,由如下重量份数的原料制成:芦荟260份、决明子100份、郁李仁160份、当归120份、黄精40份、玉竹120份、枳实120份、百合120份、火麻仁50份和黑芝麻200份。
3.根据权利要求1所述的通便排毒的中药制剂,其特征在于,由如下重量份数的原料制成:芦荟240份、决明子140份、郁李仁150份、当归120份、黄精90份、玉竹70份、枳实180份、百合60份、火麻仁80份和黑芝麻90份。
4.根据权利要求1所述的通便排毒的中药制剂,其特征在于,由如下重量份数的原料制成:芦荟300份、决明子60份、郁李仁150份、当归60份、黄精200份、玉竹40份、枳实180份、百合40份、火麻仁100份和黑芝麻60份。
5.一种通便排毒的中药制剂的制备方法,其特征在于,包括如下步骤:
步骤1:取如下重量份数的原料:芦荟150-400份、决明子60-200份、郁李仁100-300份、当归60-200份、黄精40-200份、玉竹40-120份、枳实100-300份、百合40-120份、火麻仁50-150份和黑芝麻60-200份;
步骤2:取郁李仁、火麻仁、决明子和芦荟,混合后,采用40%v/v-80%v/v的乙醇回流1-3次,每次1-3小时,过滤、回收乙醇,浓缩,得到醇回流浸膏;
步骤3:取当归、枳实、百合、黄精、玉竹和黑芝麻,加入5-10倍量的水,煎煮1-3小时,过滤,得一次滤渣和一次滤液,向一次滤渣中再加入5-10倍量的水,煎煮1-3小时,过滤,得二次滤渣和二次滤液;合并一次滤液和二次滤液,减压浓缩,得到浸膏;
步骤4:合并步骤2得到的醇回流浸膏和步骤3得到的浸膏,加入药用菌和酵母菌发酵,低温干燥,加入药用辅料,即得到所述通便排毒的中药制剂。
6.根据权利要求5所述的通便排毒的中药制剂的制备方法,其特征在于,步骤3中,所述浸膏在65℃-70℃相对密度为1.01。
7.根据权利要求5所述的通便排毒的中药制剂的制备方法,其特征在于,步骤4中,所述药用菌为金蝉花粉;所述发酵温度为28℃-35℃,发酵时间为18h-30h。
8.根据权利要求5所述的通便排毒的中药制剂的制备方法,其特征在于,步骤4中,所述低温干燥的温度为50℃-65℃,时间为8h-12h。
9.根据权利要求5所述的通便排毒的中药制剂的制备方法,其特征在于,步骤4中,所述药用辅料为淀粉、微晶纤维素、可可豆脂、卡波姆、苯甲酸钠、泊洛沙姆和苯扎溴铵中的一种或多种。
10.根据权利要求5所述的通便排毒的中药制剂的制备方法,其特征在于,步骤4中,所述通便排毒的中药制剂的剂型为粉剂、颗粒剂、口服液、胶囊剂、膏剂、乳剂和咀嚼剂中的一种或多种。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910058431.6A CN109568491A (zh) | 2019-01-22 | 2019-01-22 | 一种通便排毒的中药制剂及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910058431.6A CN109568491A (zh) | 2019-01-22 | 2019-01-22 | 一种通便排毒的中药制剂及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN109568491A true CN109568491A (zh) | 2019-04-05 |
Family
ID=65917551
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910058431.6A Pending CN109568491A (zh) | 2019-01-22 | 2019-01-22 | 一种通便排毒的中药制剂及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109568491A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113952412A (zh) * | 2021-12-10 | 2022-01-21 | 安发(福建)生物科技有限公司 | 一种通便排毒的中药组合物及其制备方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101537108A (zh) * | 2009-04-08 | 2009-09-23 | 杨泗兴 | 一种具有通便排毒、护肤祛斑功能的组合物及制备方法 |
CN103622030A (zh) * | 2012-08-21 | 2014-03-12 | 浙江劲膳美生物科技有限公司 | 一种便秘食疗组合物及制备方法 |
CN104872774A (zh) * | 2015-06-14 | 2015-09-02 | 杜沛雨 | 一种防治便秘的功能饮料 |
CN107518394A (zh) * | 2017-10-18 | 2017-12-29 | 湖州新驰医药科技有限公司 | 一种金蝉花发酵速溶粉的生产方法 |
-
2019
- 2019-01-22 CN CN201910058431.6A patent/CN109568491A/zh active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101537108A (zh) * | 2009-04-08 | 2009-09-23 | 杨泗兴 | 一种具有通便排毒、护肤祛斑功能的组合物及制备方法 |
CN103622030A (zh) * | 2012-08-21 | 2014-03-12 | 浙江劲膳美生物科技有限公司 | 一种便秘食疗组合物及制备方法 |
CN104872774A (zh) * | 2015-06-14 | 2015-09-02 | 杜沛雨 | 一种防治便秘的功能饮料 |
CN107518394A (zh) * | 2017-10-18 | 2017-12-29 | 湖州新驰医药科技有限公司 | 一种金蝉花发酵速溶粉的生产方法 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113952412A (zh) * | 2021-12-10 | 2022-01-21 | 安发(福建)生物科技有限公司 | 一种通便排毒的中药组合物及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104606612A (zh) | 一种解酒益肾压片糖果及其制备方法 | |
CN102205107B (zh) | 一种治疗十二指肠溃疡的中药制剂及其制备方法 | |
CN102671083B (zh) | 一种婴幼儿止咳、化痰药物 | |
CN104162094A (zh) | 一种治疗肥胖型多囊卵巢综合征的中药组合物及其药物制剂 | |
CN103405738B (zh) | 一种治疗慢性胆囊炎的药物组合物 | |
CN104524416A (zh) | 一种药物组合物、用途、制备方法及由其制得的药物、食品和/或保健品 | |
CN104398654A (zh) | 一种治疗中老年人便秘的中药保健品及其制备方法 | |
CN101766787B (zh) | 治疗高热、咳喘的灌肠液 | |
CN102430076A (zh) | 一种敷脐减肥散 | |
CN104431772A (zh) | 一种润肠排毒面食制品及其制备方法 | |
CN106994141B (zh) | 一种治疗便秘的中药组合物及其制备方法 | |
CN109568491A (zh) | 一种通便排毒的中药制剂及其制备方法 | |
CN104940718A (zh) | 一种治疗慢性胆囊炎的药物组合物及其制备方法 | |
CN103110884B (zh) | 一种治疗慢性胆囊炎的中药组合物 | |
CN104800771A (zh) | 一种用于儿童夜惊症的中药制剂及其制备方法 | |
CN101468097B (zh) | 滋补肝肾润肠通便的中药组合物、制剂及其制备方法 | |
CN103212030B (zh) | 一种治疗肝郁型乳腺增生的中药及制备方法 | |
CN103877484A (zh) | 一种治疗慢性肠炎的中药口服液 | |
CN102166300B (zh) | 治疗肺部阴虚、胃部阴虚及消渴病阴虚症状的中药制剂 | |
CN109700871A (zh) | 一种辅助治疗儿童便秘的中药组合物及其制备方法 | |
CN103720949A (zh) | 通便肠清胶囊及制备方法 | |
CN102698145B (zh) | 用于补脾止泻的中药制剂 | |
CN116570024A (zh) | 一种药食同源的组合物 | |
CN105213751A (zh) | 一种治疗咳嗽的中药组合物 | |
CN105125693A (zh) | 一种治疗急性胃炎的中药组合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190405 |